This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wozniacka, A Articles by Sysa-Jedrzejowska, A Search for Related Content PubMed PubMed Citation Articles by Wozniacka, A Articles by Sysa-Jedrzejowska, A Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHLOROQUINE Medline Plus Health Information Lupus Social Bookmarking                   What's this?

Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients

Department of Dermatology Medical University of Lodz, Lodz, Poland, wozniacka{at}bmp.net.pl

A Lesiak

Department of Dermatology Medical University of Lodz, Lodz, Poland

J Narbutt

Department of Dermatology Medical University of Lodz, Lodz, Poland

D P McCauliffe

Department of Medicine, Rutland Regional Medical Center, Rutland, Vermont, USA

A Sysa-Jedrzejowska

Department of Dermatology Medical University of Lodz, Lodz, Poland

Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex pathogenesis. Published data have revealed that serum levels of proinflammatory cytokines are increased in SLE patients.

The aim of our study was to evaluate whether monotherapy with chloroquine phosphate affects IL- 1ß, IL-6, IL-18 and TNF- serum levels in SLE patients. The study group consisted of 25 SLE patients with mild or moderate disease activity and 25 age- and sex-matched healthy control subjects. In SLE patients the cytokine levels were measured just before and three months after starting chloroquine treatment at a dose of 125 mg twice daily.

Although the majority of SLE patients had a low systemic lupus activity measure (SLAM) index, the levels of IL-6, IL-18 and TNF- were significantly higher than in the control group. After three-months of chloroquine therapy the mean level of IL-6, IL-18 and TNF- decreased significantly. Minimal erythema doses (MEDs) were significantly increased in SLE patients after three months of chloroquine therapy.

The results indicate that chloroquine treatment lowers some proinflammatory cytokines and may provide a photoprotective effect.

Key Words: chloroquine • cytokine • interleukin • lupus erythematosus • tumor necrosis factor

Lupus, Vol. 15, No. 5, 268-275 (2006)
DOI: 10.1191/0961203306lu2299oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Alijotas-Reig, V. Garcia-Gimenez, F. Miro-Mur, and M. Vilardell-Tarres Delayed Immune-Mediated Adverse Effects of Polyalkylimide Dermal Fillers: Clinical Findings and Long-term Follow-up Arch Dermatol, May 1, 2008; 144(5): 637 - 642. [Abstract] [Full Text] [PDF]

				D. Neumann, T. Tschernig, D. Popa, A. Schmiedl, G. P. de Lema, K. Resch, and M. U. Martin Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms Int. Immunol., December 1, 2006; 18(12): 1779 - 1787. [Abstract] [Full Text] [PDF]